Kenvue Inc. closed 6.21% short of its 52-week high of $24.46, which the company reached on November 26th.

Kenvue Inc. closed 5.19% short of its 52-week high of $24.46, which the company achieved on November 26th.

In appraisal of Kenvue’s visual identity, the logo for the independent new company is said to represent Johnson & Johnson’s timelessness, while “allowing space for its iconic brands to have ...

Kenvue (KVUE) announced a five-year collaboration with Microsoft (MSFT) which aims to establish a strong foundation for transforming digital ...

SUMMIT, N.J., April 16, 2025--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration ...

Redburn Atlantic initiated coverage of Kenvue (KVUE) with a Neutral rating and $23.50 price target The company’s first two years as a public ...

The board of Kenvue Inc. (NYSE:KVUE) has announced that it will pay a dividend of $0.205 per share on the 28th of May. Based on this payment, the dividend yield on the company's stock will be 3.5% ...

Kenvue Inc. has announced a five-year collaboration with Microsoft, to establish a strong foundation for transforming digital operations through advanced Artificial Intelligence (AI) technologies.

Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft which aims to establish a strong ...

SUMMIT, N.J. — Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft which aims to establish a ...